Multidrug resistance modulation in vivo: The effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1999-07

AUTHORS

F. Pea, D. Damiani, M. Michieli, A. Ermacora, M. Baraldo, D. Russo, R. Fanin, M. Baccarani, M. Furlanut

ABSTRACT

OBJECTIVE: To determine the effect of the coadministration of the multidrug resistance (MDR) modulators cyclosporin A (CyA) alone or plus dexverapamil (D-Ver) on idarubicin (IDA) pharmacokinetics in patients with acute leukemia. METHODS: Pharmacokinetic studies were performed in 27 patients with a diagnosis of acute myelogenous leukemia (AML), who were being treated with a combination chemotherapy regimen including idarubicin and cytarabine for the induction of a first remission (n = 14), or of a second remission (n = 7), or for remission consolidation (n = 6). Of these 27 patients, nine were coadministered CyA and seven were coadministered CyA plus D-Ver as MDR modulators. Blood was sampled at appropriate intervals after each of the three IDA daily administrations. IDA and idarubicinol (IDAOL) were assayed by HPLC. Pharmacokinetic evaluations were performed by means of a two-compartment open model with zero-order absorption and first-order elimination using the WinNonlin pharmacokinetic software package. RESULTS: CyA markedly increased the area under the concentration time-curve (AUC) of both IDA [558.26 (197.25) microg x h x l(-1) vs 315.44 (158.28) microg x h x l(-1); P < 0.01] and IDAOL [2896.60 (736.38) microg x h x l(-1) vs 1028.49 (603.95) microg x h x l(-1); P < 0.001] when coadministered as a single modulator, due to a lower total body clearance (CL) [83.51 (52.44) l x h(-1) x m(-2) vs 139.65 (69.45) l x h(-1) x m(-2); NS]. When patients received two MDR modulators simultaneously (D-Ver plus CyA), IDA exposure was essentially the same as in those of the no inhibitor group [331.29 (95.49) microg x h x l(-1) vs 315.44 (158.28) microg x h x l(-1); NS], whereas the IDAOL total body exposure was greater than in the no inhibitor group [2030.32 (401.11) microg x h x l(-1) vs 1028.49 (603.95) microg x h x l(-1); P < 0.01], even if less than in patients receiving CyA as a single MDR modulator (IDA + CyA group) [AUC 2030.32 (401.11) microg x h x l(-1) vs 2896.60 (736.38) microg x h x l(-1); P < 0.05], suggesting an antagonistic effect against those of CyA on IDA and IDAOL elimination and/or an unpredictable redistribution. The main pharmacokinetic parameters of IDA, such as CL and volume of distribution at steady state (Vdss), were remarkably affected by the coadministration of CyA or CyA plus D-Ver, but no statistically significant difference was noted because of IDA pharmacokinetic interpatient variation. CONCLUSION: The results show that CyA alone at a dose of 10 mg x kg(-1) daily significantly increased systemic body exposure to both IDA and IDAOL in acute leukemia, and suggest that these pharmacokinetic effects were at least partially decreased when D-Ver was coadministered with CyA. Our findings raise important questions concerning the need for a dosage adjustment of IDA when MDR modulators are coadministered. More... »

PAGES

361-368

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002280050641

DOI

http://dx.doi.org/10.1007/s002280050641

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049519532

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10456485


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclosporine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Multiple", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Idarubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Acute", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Verapamil", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Udine", 
          "id": "https://www.grid.ac/institutes/grid.5390.f", 
          "name": [
            "Institute of Clinical Pharmacology and Toxicology, DPMSC University of Udine, P. le S.M. Misericordia 3, I-33100 Udine, Italy email: mario.furlanut@dpmsc.uniud.it Tel.:/Fax: +39-432-559833, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pea", 
        "givenName": "F.", 
        "id": "sg:person.0725711337.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725711337.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria della Misericordia di Udine", 
          "id": "https://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Division of Hematology, Department of Bone Marrow Transplantation, Udine University Hospital, Udine, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Damiani", 
        "givenName": "D.", 
        "id": "sg:person.01104271471.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104271471.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria della Misericordia di Udine", 
          "id": "https://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Division of Hematology, Department of Bone Marrow Transplantation, Udine University Hospital, Udine, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Michieli", 
        "givenName": "M.", 
        "id": "sg:person.0633657425.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633657425.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria della Misericordia di Udine", 
          "id": "https://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Division of Hematology, Department of Bone Marrow Transplantation, Udine University Hospital, Udine, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ermacora", 
        "givenName": "A.", 
        "id": "sg:person.01310754205.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310754205.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Udine", 
          "id": "https://www.grid.ac/institutes/grid.5390.f", 
          "name": [
            "Institute of Clinical Pharmacology and Toxicology, DPMSC University of Udine, P. le S.M. Misericordia 3, I-33100 Udine, Italy email: mario.furlanut@dpmsc.uniud.it Tel.:/Fax: +39-432-559833, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baraldo", 
        "givenName": "M.", 
        "id": "sg:person.0734230340.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734230340.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria della Misericordia di Udine", 
          "id": "https://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Division of Hematology, Department of Bone Marrow Transplantation, Udine University Hospital, Udine, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Russo", 
        "givenName": "D.", 
        "id": "sg:person.01033477037.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033477037.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria della Misericordia di Udine", 
          "id": "https://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Division of Hematology, Department of Bone Marrow Transplantation, Udine University Hospital, Udine, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fanin", 
        "givenName": "R.", 
        "id": "sg:person.01364770162.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364770162.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria della Misericordia di Udine", 
          "id": "https://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Division of Hematology, Department of Bone Marrow Transplantation, Udine University Hospital, Udine, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baccarani", 
        "givenName": "M.", 
        "id": "sg:person.01016466503.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016466503.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Udine", 
          "id": "https://www.grid.ac/institutes/grid.5390.f", 
          "name": [
            "Institute of Clinical Pharmacology and Toxicology, DPMSC University of Udine, P. le S.M. Misericordia 3, I-33100 Udine, Italy email: mario.furlanut@dpmsc.uniud.it Tel.:/Fax: +39-432-559833, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Furlanut", 
        "givenName": "M.", 
        "id": "sg:person.01156366337.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156366337.91"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001041614"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0609.1994.tb00096.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001285217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0609.1994.tb00096.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001285217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00686300", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002029939", 
          "https://doi.org/10.1007/bf00686300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00686300", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002029939", 
          "https://doi.org/10.1007/bf00686300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0145-2126(94)90025-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003577353"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-199324040-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003632761", 
          "https://doi.org/10.2165/00003088-199324040-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00686409", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004453298", 
          "https://doi.org/10.1007/bf00686409"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00686409", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004453298", 
          "https://doi.org/10.1007/bf00686409"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19900901)66:5<868::aid-cncr2820660510>3.0.co;2-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007644977"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1988.tb05277.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008161434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1146/annurev.pa.36.040196.001113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010847748"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007890-198802000-00038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013510165"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007890-198802000-00038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013510165"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007890-198802000-00038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013510165"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001813-199601000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018263322"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001813-199601000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018263322"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10428199309059575", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029443732"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/02841869209088904", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030281642"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0925-4439(96)00008-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033318084"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03259110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040762750", 
          "https://doi.org/10.1007/bf03259110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03259110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040762750", 
          "https://doi.org/10.1007/bf03259110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02480194", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042693900", 
          "https://doi.org/10.1007/bf02480194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02480194", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042693900", 
          "https://doi.org/10.1007/bf02480194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00273394", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043950975", 
          "https://doi.org/10.1007/bf00273394"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00273394", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043950975", 
          "https://doi.org/10.1007/bf00273394"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10428199609054807", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044445113"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01117450", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046170033", 
          "https://doi.org/10.1007/bf01117450"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1349-7006.1990.tb02653.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048207177"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1349-7006.1990.tb02653.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048207177"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10428199309147379", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050842340"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01757351", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053701419", 
          "https://doi.org/10.1007/bf01757351"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01757351", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053701419", 
          "https://doi.org/10.1007/bf01757351"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1992.10.10.1624", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1076202586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1992.10.10.1635", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1076202587"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1995.13.8.1985", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082444244"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ndt/9.8.1143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082513125"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1993.11.9.1629", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082771850"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1999-07", 
    "datePublishedReg": "1999-07-01", 
    "description": "OBJECTIVE: To determine the effect of the coadministration of the multidrug resistance (MDR) modulators cyclosporin A (CyA) alone or plus dexverapamil (D-Ver) on idarubicin (IDA) pharmacokinetics in patients with acute leukemia.\nMETHODS: Pharmacokinetic studies were performed in 27 patients with a diagnosis of acute myelogenous leukemia (AML), who were being treated with a combination chemotherapy regimen including idarubicin and cytarabine for the induction of a first remission (n = 14), or of a second remission (n = 7), or for remission consolidation (n = 6). Of these 27 patients, nine were coadministered CyA and seven were coadministered CyA plus D-Ver as MDR modulators. Blood was sampled at appropriate intervals after each of the three IDA daily administrations. IDA and idarubicinol (IDAOL) were assayed by HPLC. Pharmacokinetic evaluations were performed by means of a two-compartment open model with zero-order absorption and first-order elimination using the WinNonlin pharmacokinetic software package.\nRESULTS: CyA markedly increased the area under the concentration time-curve (AUC) of both IDA [558.26 (197.25) microg x h x l(-1) vs 315.44 (158.28) microg x h x l(-1); P < 0.01] and IDAOL [2896.60 (736.38) microg x h x l(-1) vs 1028.49 (603.95) microg x h x l(-1); P < 0.001] when coadministered as a single modulator, due to a lower total body clearance (CL) [83.51 (52.44) l x h(-1) x m(-2) vs 139.65 (69.45) l x h(-1) x m(-2); NS]. When patients received two MDR modulators simultaneously (D-Ver plus CyA), IDA exposure was essentially the same as in those of the no inhibitor group [331.29 (95.49) microg x h x l(-1) vs 315.44 (158.28) microg x h x l(-1); NS], whereas the IDAOL total body exposure was greater than in the no inhibitor group [2030.32 (401.11) microg x h x l(-1) vs 1028.49 (603.95) microg x h x l(-1); P < 0.01], even if less than in patients receiving CyA as a single MDR modulator (IDA + CyA group) [AUC 2030.32 (401.11) microg x h x l(-1) vs 2896.60 (736.38) microg x h x l(-1); P < 0.05], suggesting an antagonistic effect against those of CyA on IDA and IDAOL elimination and/or an unpredictable redistribution. The main pharmacokinetic parameters of IDA, such as CL and volume of distribution at steady state (Vdss), were remarkably affected by the coadministration of CyA or CyA plus D-Ver, but no statistically significant difference was noted because of IDA pharmacokinetic interpatient variation.\nCONCLUSION: The results show that CyA alone at a dose of 10 mg x kg(-1) daily significantly increased systemic body exposure to both IDA and IDAOL in acute leukemia, and suggest that these pharmacokinetic effects were at least partially decreased when D-Ver was coadministered with CyA. Our findings raise important questions concerning the need for a dosage adjustment of IDA when MDR modulators are coadministered.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s002280050641", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "55"
      }
    ], 
    "name": "Multidrug resistance modulation in vivo: The effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia", 
    "pagination": "361-368", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "ebe5fe383797f95646cc7f10d364118e0ff293d9246fabe5a7223771896b1b80"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10456485"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "1256165"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002280050641"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049519532"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002280050641", 
      "https://app.dimensions.ai/details/publication/pub.1049519532"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000516.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs002280050641"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002280050641'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002280050641'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002280050641'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002280050641'


 

This table displays all metadata directly associated to this object as RDF triples.

249 TRIPLES      21 PREDICATES      64 URIs      29 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002280050641 schema:about N332684dbd2ff4a528173d943a9ee56bc
2 N4032cd06efd347eb84e2a8368a9e5840
3 N51a3961270c543b1b7b2309d12ab0c0f
4 N608f82a7dbbc4b74a19500d7e65fbd3b
5 N9539b952efbf477fba01b5967d1399b5
6 Na37b6505c93b458695325b79bb3f203c
7 Ne533a498291044fd93d54b006f7d2fce
8 Nf6aff38e9c8c43d6a996773675ce340a
9 anzsrc-for:11
10 anzsrc-for:1112
11 schema:author N92126ea1847a4e328cad553f0a4c7c7c
12 schema:citation sg:pub.10.1007/bf00273394
13 sg:pub.10.1007/bf00686300
14 sg:pub.10.1007/bf00686409
15 sg:pub.10.1007/bf01117450
16 sg:pub.10.1007/bf01757351
17 sg:pub.10.1007/bf02480194
18 sg:pub.10.1007/bf03259110
19 sg:pub.10.2165/00003088-199324040-00002
20 https://doi.org/10.1002/1097-0142(19900901)66:5<868::aid-cncr2820660510>3.0.co;2-z
21 https://doi.org/10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r
22 https://doi.org/10.1016/0145-2126(94)90025-6
23 https://doi.org/10.1016/0925-4439(96)00008-7
24 https://doi.org/10.1093/ndt/9.8.1143
25 https://doi.org/10.1097/00001813-199601000-00007
26 https://doi.org/10.1097/00007890-198802000-00038
27 https://doi.org/10.1111/j.1349-7006.1990.tb02653.x
28 https://doi.org/10.1111/j.1365-2125.1988.tb05277.x
29 https://doi.org/10.1111/j.1600-0609.1994.tb00096.x
30 https://doi.org/10.1146/annurev.pa.36.040196.001113
31 https://doi.org/10.1200/jco.1992.10.10.1624
32 https://doi.org/10.1200/jco.1992.10.10.1635
33 https://doi.org/10.1200/jco.1993.11.9.1629
34 https://doi.org/10.1200/jco.1995.13.8.1985
35 https://doi.org/10.3109/02841869209088904
36 https://doi.org/10.3109/10428199309059575
37 https://doi.org/10.3109/10428199309147379
38 https://doi.org/10.3109/10428199609054807
39 schema:datePublished 1999-07
40 schema:datePublishedReg 1999-07-01
41 schema:description OBJECTIVE: To determine the effect of the coadministration of the multidrug resistance (MDR) modulators cyclosporin A (CyA) alone or plus dexverapamil (D-Ver) on idarubicin (IDA) pharmacokinetics in patients with acute leukemia. METHODS: Pharmacokinetic studies were performed in 27 patients with a diagnosis of acute myelogenous leukemia (AML), who were being treated with a combination chemotherapy regimen including idarubicin and cytarabine for the induction of a first remission (n = 14), or of a second remission (n = 7), or for remission consolidation (n = 6). Of these 27 patients, nine were coadministered CyA and seven were coadministered CyA plus D-Ver as MDR modulators. Blood was sampled at appropriate intervals after each of the three IDA daily administrations. IDA and idarubicinol (IDAOL) were assayed by HPLC. Pharmacokinetic evaluations were performed by means of a two-compartment open model with zero-order absorption and first-order elimination using the WinNonlin pharmacokinetic software package. RESULTS: CyA markedly increased the area under the concentration time-curve (AUC) of both IDA [558.26 (197.25) microg x h x l(-1) vs 315.44 (158.28) microg x h x l(-1); P < 0.01] and IDAOL [2896.60 (736.38) microg x h x l(-1) vs 1028.49 (603.95) microg x h x l(-1); P < 0.001] when coadministered as a single modulator, due to a lower total body clearance (CL) [83.51 (52.44) l x h(-1) x m(-2) vs 139.65 (69.45) l x h(-1) x m(-2); NS]. When patients received two MDR modulators simultaneously (D-Ver plus CyA), IDA exposure was essentially the same as in those of the no inhibitor group [331.29 (95.49) microg x h x l(-1) vs 315.44 (158.28) microg x h x l(-1); NS], whereas the IDAOL total body exposure was greater than in the no inhibitor group [2030.32 (401.11) microg x h x l(-1) vs 1028.49 (603.95) microg x h x l(-1); P < 0.01], even if less than in patients receiving CyA as a single MDR modulator (IDA + CyA group) [AUC 2030.32 (401.11) microg x h x l(-1) vs 2896.60 (736.38) microg x h x l(-1); P < 0.05], suggesting an antagonistic effect against those of CyA on IDA and IDAOL elimination and/or an unpredictable redistribution. The main pharmacokinetic parameters of IDA, such as CL and volume of distribution at steady state (Vdss), were remarkably affected by the coadministration of CyA or CyA plus D-Ver, but no statistically significant difference was noted because of IDA pharmacokinetic interpatient variation. CONCLUSION: The results show that CyA alone at a dose of 10 mg x kg(-1) daily significantly increased systemic body exposure to both IDA and IDAOL in acute leukemia, and suggest that these pharmacokinetic effects were at least partially decreased when D-Ver was coadministered with CyA. Our findings raise important questions concerning the need for a dosage adjustment of IDA when MDR modulators are coadministered.
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree false
45 schema:isPartOf N674a9383bef345c1896dd63e211460e4
46 Nee7ae48f765c41e4888ea7283b294fed
47 sg:journal.1054337
48 schema:name Multidrug resistance modulation in vivo: The effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia
49 schema:pagination 361-368
50 schema:productId N9874d32dfe8e48d0b1b34e7ae7796504
51 N9ac2515bd3b443dd813a9a7456c4cbe6
52 Nabb84191f9d24f4d992f0ec4278532cc
53 Nbfa7b75c0f5c41ec94a0675be1a0dd46
54 Nf5866b2f8c4346fc9f85dbabe289ebd0
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049519532
56 https://doi.org/10.1007/s002280050641
57 schema:sdDatePublished 2019-04-10T17:33
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher N960a0b38d19d4d1da717e266474e1514
60 schema:url http://link.springer.com/10.1007%2Fs002280050641
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N09b2b47875c74f8786c506c044a1f906 rdf:first sg:person.01156366337.91
65 rdf:rest rdf:nil
66 N19a1097efc2f4b3f9540614dd73a34ed rdf:first sg:person.01016466503.33
67 rdf:rest N09b2b47875c74f8786c506c044a1f906
68 N332684dbd2ff4a528173d943a9ee56bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Drug Therapy, Combination
70 rdf:type schema:DefinedTerm
71 N4032cd06efd347eb84e2a8368a9e5840 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Humans
73 rdf:type schema:DefinedTerm
74 N4b0c5799e5e540a8a746bad91058d7df rdf:first sg:person.01310754205.76
75 rdf:rest N53b705e2186442a8b7649b06b68b3fee
76 N51a3961270c543b1b7b2309d12ab0c0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Drug Resistance, Multiple
78 rdf:type schema:DefinedTerm
79 N53b705e2186442a8b7649b06b68b3fee rdf:first sg:person.0734230340.16
80 rdf:rest Na7500b082a254fe7b099300b07ebbb85
81 N608f82a7dbbc4b74a19500d7e65fbd3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Leukemia, Myeloid, Acute
83 rdf:type schema:DefinedTerm
84 N674a9383bef345c1896dd63e211460e4 schema:issueNumber 5
85 rdf:type schema:PublicationIssue
86 N68b4c1b8649642d78dd45b0345c94f47 rdf:first sg:person.01364770162.44
87 rdf:rest N19a1097efc2f4b3f9540614dd73a34ed
88 N92126ea1847a4e328cad553f0a4c7c7c rdf:first sg:person.0725711337.51
89 rdf:rest Nee6c501a388847e79642603d0e9ee780
90 N9539b952efbf477fba01b5967d1399b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Idarubicin
92 rdf:type schema:DefinedTerm
93 N960a0b38d19d4d1da717e266474e1514 schema:name Springer Nature - SN SciGraph project
94 rdf:type schema:Organization
95 N9874d32dfe8e48d0b1b34e7ae7796504 schema:name readcube_id
96 schema:value ebe5fe383797f95646cc7f10d364118e0ff293d9246fabe5a7223771896b1b80
97 rdf:type schema:PropertyValue
98 N9ac2515bd3b443dd813a9a7456c4cbe6 schema:name pubmed_id
99 schema:value 10456485
100 rdf:type schema:PropertyValue
101 N9d1c9765082c4cc082d5b601bc081169 rdf:first sg:person.0633657425.75
102 rdf:rest N4b0c5799e5e540a8a746bad91058d7df
103 Na37b6505c93b458695325b79bb3f203c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Cyclosporine
105 rdf:type schema:DefinedTerm
106 Na7500b082a254fe7b099300b07ebbb85 rdf:first sg:person.01033477037.24
107 rdf:rest N68b4c1b8649642d78dd45b0345c94f47
108 Nabb84191f9d24f4d992f0ec4278532cc schema:name doi
109 schema:value 10.1007/s002280050641
110 rdf:type schema:PropertyValue
111 Nbfa7b75c0f5c41ec94a0675be1a0dd46 schema:name nlm_unique_id
112 schema:value 1256165
113 rdf:type schema:PropertyValue
114 Ne533a498291044fd93d54b006f7d2fce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Time Factors
116 rdf:type schema:DefinedTerm
117 Nee6c501a388847e79642603d0e9ee780 rdf:first sg:person.01104271471.84
118 rdf:rest N9d1c9765082c4cc082d5b601bc081169
119 Nee7ae48f765c41e4888ea7283b294fed schema:volumeNumber 55
120 rdf:type schema:PublicationVolume
121 Nf5866b2f8c4346fc9f85dbabe289ebd0 schema:name dimensions_id
122 schema:value pub.1049519532
123 rdf:type schema:PropertyValue
124 Nf6aff38e9c8c43d6a996773675ce340a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Verapamil
126 rdf:type schema:DefinedTerm
127 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
128 schema:name Medical and Health Sciences
129 rdf:type schema:DefinedTerm
130 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
131 schema:name Oncology and Carcinogenesis
132 rdf:type schema:DefinedTerm
133 sg:journal.1054337 schema:issn 0031-6970
134 1432-1041
135 schema:name European Journal of Clinical Pharmacology
136 rdf:type schema:Periodical
137 sg:person.01016466503.33 schema:affiliation https://www.grid.ac/institutes/grid.411492.b
138 schema:familyName Baccarani
139 schema:givenName M.
140 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016466503.33
141 rdf:type schema:Person
142 sg:person.01033477037.24 schema:affiliation https://www.grid.ac/institutes/grid.411492.b
143 schema:familyName Russo
144 schema:givenName D.
145 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033477037.24
146 rdf:type schema:Person
147 sg:person.01104271471.84 schema:affiliation https://www.grid.ac/institutes/grid.411492.b
148 schema:familyName Damiani
149 schema:givenName D.
150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104271471.84
151 rdf:type schema:Person
152 sg:person.01156366337.91 schema:affiliation https://www.grid.ac/institutes/grid.5390.f
153 schema:familyName Furlanut
154 schema:givenName M.
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156366337.91
156 rdf:type schema:Person
157 sg:person.01310754205.76 schema:affiliation https://www.grid.ac/institutes/grid.411492.b
158 schema:familyName Ermacora
159 schema:givenName A.
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310754205.76
161 rdf:type schema:Person
162 sg:person.01364770162.44 schema:affiliation https://www.grid.ac/institutes/grid.411492.b
163 schema:familyName Fanin
164 schema:givenName R.
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364770162.44
166 rdf:type schema:Person
167 sg:person.0633657425.75 schema:affiliation https://www.grid.ac/institutes/grid.411492.b
168 schema:familyName Michieli
169 schema:givenName M.
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633657425.75
171 rdf:type schema:Person
172 sg:person.0725711337.51 schema:affiliation https://www.grid.ac/institutes/grid.5390.f
173 schema:familyName Pea
174 schema:givenName F.
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725711337.51
176 rdf:type schema:Person
177 sg:person.0734230340.16 schema:affiliation https://www.grid.ac/institutes/grid.5390.f
178 schema:familyName Baraldo
179 schema:givenName M.
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734230340.16
181 rdf:type schema:Person
182 sg:pub.10.1007/bf00273394 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043950975
183 https://doi.org/10.1007/bf00273394
184 rdf:type schema:CreativeWork
185 sg:pub.10.1007/bf00686300 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002029939
186 https://doi.org/10.1007/bf00686300
187 rdf:type schema:CreativeWork
188 sg:pub.10.1007/bf00686409 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004453298
189 https://doi.org/10.1007/bf00686409
190 rdf:type schema:CreativeWork
191 sg:pub.10.1007/bf01117450 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046170033
192 https://doi.org/10.1007/bf01117450
193 rdf:type schema:CreativeWork
194 sg:pub.10.1007/bf01757351 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053701419
195 https://doi.org/10.1007/bf01757351
196 rdf:type schema:CreativeWork
197 sg:pub.10.1007/bf02480194 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042693900
198 https://doi.org/10.1007/bf02480194
199 rdf:type schema:CreativeWork
200 sg:pub.10.1007/bf03259110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040762750
201 https://doi.org/10.1007/bf03259110
202 rdf:type schema:CreativeWork
203 sg:pub.10.2165/00003088-199324040-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003632761
204 https://doi.org/10.2165/00003088-199324040-00002
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1002/1097-0142(19900901)66:5<868::aid-cncr2820660510>3.0.co;2-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1007644977
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r schema:sameAs https://app.dimensions.ai/details/publication/pub.1001041614
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1016/0145-2126(94)90025-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003577353
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1016/0925-4439(96)00008-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033318084
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1093/ndt/9.8.1143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082513125
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1097/00001813-199601000-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018263322
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1097/00007890-198802000-00038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013510165
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1111/j.1349-7006.1990.tb02653.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1048207177
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1111/j.1365-2125.1988.tb05277.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1008161434
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1111/j.1600-0609.1994.tb00096.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001285217
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1146/annurev.pa.36.040196.001113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010847748
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1200/jco.1992.10.10.1624 schema:sameAs https://app.dimensions.ai/details/publication/pub.1076202586
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1200/jco.1992.10.10.1635 schema:sameAs https://app.dimensions.ai/details/publication/pub.1076202587
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1200/jco.1993.11.9.1629 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082771850
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1200/jco.1995.13.8.1985 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082444244
235 rdf:type schema:CreativeWork
236 https://doi.org/10.3109/02841869209088904 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030281642
237 rdf:type schema:CreativeWork
238 https://doi.org/10.3109/10428199309059575 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029443732
239 rdf:type schema:CreativeWork
240 https://doi.org/10.3109/10428199309147379 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050842340
241 rdf:type schema:CreativeWork
242 https://doi.org/10.3109/10428199609054807 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044445113
243 rdf:type schema:CreativeWork
244 https://www.grid.ac/institutes/grid.411492.b schema:alternateName Ospedale Santa Maria della Misericordia di Udine
245 schema:name Division of Hematology, Department of Bone Marrow Transplantation, Udine University Hospital, Udine, Italy, IT
246 rdf:type schema:Organization
247 https://www.grid.ac/institutes/grid.5390.f schema:alternateName University of Udine
248 schema:name Institute of Clinical Pharmacology and Toxicology, DPMSC University of Udine, P. le S.M. Misericordia 3, I-33100 Udine, Italy email: mario.furlanut@dpmsc.uniud.it Tel.:/Fax: +39-432-559833, IT
249 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...